{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:34:34Z","timestamp":1792146874037,"version":"4.4.0"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.958","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T05:57:45Z","timestamp":1130479065000},"page":"958-962","source":"Crossref","is-referenced-by-count":19,"title":["Primary Hepatic Carcinoid Tumor with Carcinoid Syndrome and Carcinoid Heart Disease: A Case Report of a Patient on Long-Term Follow-up"],"prefix":"10.2169","volume":"44","author":[{"given":"Tatsuhiko","family":"TOHYAMA","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kohryo Clinic, Takaoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"MATSUI","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, Toyama Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"KITAGAWA","sequence":"additional","affiliation":[{"name":"Department of Radiology, Takaoka Kohseiren Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1) Sano K, Kosuge T, Yamamoto J, et al. Primary hepatic carcinoid tumors confirmed with long-term follow-up after resection. Hepatogastroenterology <b>46<\/b>: 2547-2550, 1999."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tornebrandt K, Eskilsson J, Nobin A. Heart involvement in metastatic carcinoid disease. Clin Cardiol <b>9<\/b>: 13-19, 1986.","DOI":"10.1002\/clc.4960090104"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Moller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA. Factors associated with progression of carcinoid heart disease. N Engl J Med <b>348<\/b>: 1005-1015, 2003.","DOI":"10.1056\/NEJMoa021451"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients. Circulation <b>87<\/b>: 1188-1196, 1993.","DOI":"10.1161\/01.CIR.87.4.1188"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mehta DC, Warner RR, Parnes I, Weiss M. An 18-year follow-up of primary hepatic carcinoid with carcinoid syndrome. J Clin Gastrenterol <b>23<\/b>: 60-62, 1996.","DOI":"10.1097\/00004836-199607000-00017"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ahlman H, Westberg G, W&auml;ngberg B, et al. Treatment of liver metastases of carcinoid tumors. World J Surg <b>20<\/b>: 196-202, 1996.","DOI":"10.1007\/s002689900030"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kvols LK, Moertel CG, O&rsquo;Connell MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome: evaluation of a long acting somatostatin analogue. N Engl J Med <b>315<\/b>: 663-666, 1986.","DOI":"10.1056\/NEJM198609113151102"},{"issue":"2","key":"8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2169\/internalmedicine.33.100","volume":"33","author":"DEGUCHI H","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0918-2918","issn-type":"print"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199808000-00003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Godwin JD II. Carcinoid tumors. An analysis of 2,837 cases. Cancer <b>36<\/b>: 560-569, 1975.","DOI":"10.1002\/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lips CJ, Lentjes EG, H&ouml;ppener JW. The spectrum of carcinoid tumours and carcinoid syndrome. Ann Clin Biochem <b>40<\/b>: 612-627, 2003.","DOI":"10.1258\/000456303770367207"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zuetenhorst JM, Bonfrer JM, Korse CM, Bakkec R, van Tinteren H, Taal BG. Carcinoid heart disease: The role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-&beta; and fibroblast growth factor. Cancer <b>97<\/b>: 1609-1615, 2003.","DOI":"10.1002\/cncr.11226"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Moertel CG, Kvols LK, O&rsquo;Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer <b>68<\/b>: 227-232, 1991.","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/9\/44_9_958\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:24:51Z","timestamp":1621445091000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/9\/44_9_958\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.958","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}